Polyclonal Rabbit anti‑Mouse QRFPR / GPR103 Antibody (CF, aa401‑433) LS‑C184103
Polyclonal Rabbit anti‑Mouse QRFPR / GPR103 Antibody (CF, aa401‑433) LS‑C184103
Antibody:
QRFPR / GPR103 Rabbit anti-Mouse Polyclonal (aa401-433) (CF) Antibody
Format:
Carboxyfluorescein, Unmodified
Overview
Antibody:
QRFPR / GPR103 Rabbit anti-Mouse Polyclonal (aa401-433) (CF) Antibody
Format:
Carboxyfluorescein, Unmodified
Specifications
Description
GPR103 antibody LS-C184103 is a CF-conjugated rabbit polyclonal antibody to mouse GPR103 (QRFPR) (aa401-433). Validated for ELISA.
Target
Mouse QRFPR / GPR103
Synonyms
QRFPR | AQ27 | G protein-coupled receptor 103 | QRFP receptor | SP9155 | G-protein coupled receptor 103 | GPR103
Reactivity
Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Carboxyfluorescein
Immunogen
Synthetic peptide corresponding to aa401-433 of mouse QRFP receptor AQ27.
Specificity
Mouse QRFP receptor AQ27.
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Storage
May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for up to 1 year. Protect from light.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin
Species:
Human
Applications:
Western blot, ELISA
Species:
Human, Bovine, Horse, Pig, Rabbit
Applications:
IHC, IHC - Paraffin
Species:
Human, Mouse, Rat
Applications:
Immunofluorescence, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Mouse, Rat
Applications:
Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Mouse, Rat
Applications:
Immunofluorescence, Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/22/2024